What is Briacell Therapeutics Corp (BCTX) stock price today?

Briacell Therapeutics Corp (BCTX) currently trades at $4.18 per share. The stock has a market capitalization of $28.13M and a P/E ratio of —x.

Is BCTX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Briacell Therapeutics Corp has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

BCTX

Briacell Therapeutics Corp

NASDAQ: BCTX · HEALTHCARE · BIOTECHNOLOGY

$4.18

+3.98% today

Updated 2026-04-30

Market cap

$28.13M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-14.42

Dividend yield

—

52W range

$4 – $50

Volume

0.2M

Market cap

$28.13M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-14.42

Dividend yield

—

52W range

$4 – $50

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$150.00

+3488.52%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-8.11M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	—	$0.00
Net income	$-34.13M	$-27.27M	$-6.55M	$-36.50M	$-7.35M
EPS	—	—	—	—	$-14.42
Free cash flow	$-15.87M	$-31.89M	$-33.59M	$-39.07M	$-8.11M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BCTX	$28.13M	26	4.3	3.0	5.0	5.0	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Briacell Therapeutics Corp trades at $4.18. Our Smart Value Score of 26/100 indicates the stock is weak.

Frequently asked questions

What is Briacell Therapeutics Corp's stock price?

Briacell Therapeutics Corp (BCTX) trades at $4.18.

Is Briacell Therapeutics Corp overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of Briacell Therapeutics Corp (BCTX)?

The analyst target price is $150.00, representing +3488.5% upside from the current price of $4.18.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-179.20%

Beta1.63

50D MA$4.12

200D MA$7.69

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

BCTX vs LLY →BCTX vs JNJ →BCTX vs ABBV →Stock screener →